In a study of 3 hospitals in Massachusetts, more than a quarter of patient orders were considered partially defensive medicine, but they only accounted for 13% of costs.
In a study of 3 hospitals in Massachusetts, more than a quarter of patient orders were considered partially defensive medicine, but they only accounted for 13% of costs, according to a summary published in JAMA.
Defensive medicine is the overuse of tests and procedures because of fear of malpractice litigation, and it is estimated to cost $46 billion annually in the United States. According to the data compiled from 39 participating physicians at Baystate Medical Center, Baystate Franklin Medical Center, and Baystate Mary Lane Hospital, just 13% of hospital costs could be considered at least partially defensive.
The physicians were asked to look through their orders from the previous day and indicate on a 5-point scale (with 0 being “not at all defensive” and 4 being “completely defensive”) the extent to which each one was ordered primarily because of malpractice concerns.
Overall, there were 4215 orders for 769 patients. The physicians generated a median of 3 orders per patient and 97 per physician, and 28% were considered defensive. Only 4 out of the 39 physicians identified no defensive orders, while 21 rated at least 1 order as “mostly defensive.”
Being more defensive did not increase costs per patient, the authors found. Compared with physicians with fewer defensive orders, those with at least 10% defensive orders placed a similar number of orders (5.4 vs 4.9) and generated similar costs per patient ($1679 vs $1700).
Completely defensive orders represented 2.9% of hospital costs. According to the investigators, most costs were due to potentially unnecessary hospitalizations, which accounted for 82% of all defensive orders.
Based on the information on demographics and attitudes toward defensive medicine gathered on the physicians, there were no factors were associated with defensive orders or cost.
“Defensive medicine practices varied substantially, but physicians who wrote the most defensive orders spent less than those who wrote fewer such orders, highlighting the disconnect between physician beliefs about defensive medicine and their contribution to costs,” the authors concluded.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen